These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9450153)

  • 1. Pivagabine: a novel psychoactive drug.
    Esposito G; Luparini MR
    Arzneimittelforschung; 1997 Nov; 47(11A):1306-9. PubMed ID: 9450153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress.
    Scapagnini U; Matera M
    Arzneimittelforschung; 1997 Nov; 47(11A):1310-4. PubMed ID: 9450154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pivagabine on stress-induced gastric ulcer formation in rats.
    Gianni AM; Bruno G; Sirtori C
    Arzneimittelforschung; 1997 Nov; 47(11A):1315-7. PubMed ID: 9450155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pivagabine in the management of hospitalization distress in children.
    Gelsomini S
    Arzneimittelforschung; 1997 Nov; 47(11A):1332-5. PubMed ID: 9450160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of pivagabine on insomnia associated with mood disorders.
    Negri L
    Arzneimittelforschung; 1997 Nov; 47(11A):1322-5. PubMed ID: 9450157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivagabine (Tonerg). A novel psychoactive drugs.
    Sirtori C
    Arzneimittelforschung; 1997 Nov; 47(11A):1303-5. PubMed ID: 9450152
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G; Cagnin A; Mancia D; Caffarra P; Avanzi S; Copelli S; Ciappina C; Lo Presti F; Spilimbergo PG; D'Antonio E; Di Costanzo E; Matrango M; Pastres P; Urbani PP; Signorino M; Simoncelli M; Provinciali L; Regnicolo L; Albano C; Roccatagliata G; Rubino V; Cultrera S; Fracassi M
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of the efficacy of pivagabine in the treatment of mood and adjustment disorders.
    Terranova R; Gilotta SM; Luca S
    Arzneimittelforschung; 1997 Nov; 47(11A):1325-8. PubMed ID: 9450158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivagabine-induced increases in the abundance of CRF mRNA in the cerebral cortex and hypothalamus of rats.
    Follesa P; Cagetti E; Porta S; Espositoto G; Biggio G
    Brain Res Mol Brain Res; 2000 Dec; 84(1-2):52-7. PubMed ID: 11113531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pivagabine in the treatment of climacteric syndrome.
    Gigliotti B; Multinu A; Lai VR
    Arzneimittelforschung; 1997 Nov; 47(11A):1317-21. PubMed ID: 9450156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain.
    Serra M; Concas A; Mostallino MC; Chessa MF; Stomati M; Petraglia F; Genazzani AR; Biggio G
    Psychoneuroendocrinology; 1999 Apr; 24(3):269-84. PubMed ID: 10101733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Search for and study of biologically active substances with psychotropic activity among the N-nicotinoyl derivatives of glutamic and gamma-aminobutyric acids].
    Kuz'menko GI; Gotsuliak LE; Gaĭdenko AI; Kazanov AD; Niiaka MF
    Farmakol Toksikol; 1988; 51(1):12-4. PubMed ID: 2896131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2 new GABA-ergics (GABA-linoleamide and GABA-steatamide). On 2 experimental models of depression].
    Vamvakidès A
    Agressologie; 1985 Jun; 26(7):597-9. PubMed ID: 4041141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychopharmacologic profile of a new product: GABA linoleamide (Gabalid)].
    Vamvakidès A; Papadopoulou-Daïfoli Z
    Agressologie; 1982 Oct; 23(4):123-4. PubMed ID: 7180983
    [No Abstract]   [Full Text] [Related]  

  • 15. [3 new GABA-ergics: research on their possible site of action].
    Vamvakidès A
    Agressologie; 1985 Jun; 26(7):591-4. PubMed ID: 2994504
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
    Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
    Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychoactive drugs on brain acetylcholine (Ach) levels in rats.
    Gupta SB
    Indian J Physiol Pharmacol; 1980; 24(1):71-2. PubMed ID: 7364465
    [No Abstract]   [Full Text] [Related]  

  • 18. [Place of neurometabolic stimulators (cerebroprotectors) in the current systematics of psychotropic drugs and their principal kinds of clinical activity].
    Niss AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):750-6. PubMed ID: 6464593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of psychoactive agents on the brain.
    Sloviter HA
    Psychopharmacol Bull; 1975 Jul; 11(3):71. PubMed ID: 1153683
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychotropic effect of phenibut salts and their compositions with organic acids].
    Tiurenkov IN; Bagmetova VV; Krivitskaia AN; Berestovitskaia VM; Vasil'eva OS
    Eksp Klin Farmakol; 2011; 74(2):3-7. PubMed ID: 21476277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.